Companies

See how salaries can vary from company to company

We help our clients grow, lower costs and improve productivity by creating high performing spaces that integrate architecture, flooring, furniture and technology. view company details

GeekHive is a marketing technology consultancy. We combine our expertise in digital strategy and technology implementation to help organizations improve ROI and unlock the power of their technology investments. view company details

We help our business partners achieve financial success by challenging ourselves and our customers to think differently because innovation leads to success! view company details

MassPay provides cloud-based human resource and payroll solution that help businesses optimize their workforce and streamline processes. view company details

Next Jump is the creator of Perksatwork.com, a free suite of tools designed to help improve workplace culture in companies of all shapes and sizes. view company details

Our company is built around the individuals we serve. Our programs are specifically created to help individuals work toward becoming better people and having a better life. view company details

We help transform workplaces to engage employees. By integrating furniture, technology and architectural systems we create spaces that support your best work. view company details

XANT develops a digital sales platform that uses artificial intelligence to analyze customer data and help sales and marketing teams optimize customer and lead engagement. view company details

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology for the treatment of cancer and rare genetic diseases. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA, an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has comp... view company details

OncoSec Medical Incorporated, a biotechnology company, focuses on the development of cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. The company is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in the Phase IIb clinical trials (PISCES/KEYNOTE-695) and advanced or metastatic triple negative breas... view company details

Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York. view company details

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its therapeutic candidates include luspatercept, which completed Phase III clinical trials for the treatment of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis; Phase II clinical trials for the treatment of patients with transfusion-dependent beta-thalassemia. The company is also developing and sotatercept for the treatment of patients with pulmonary hypertension. In addition, the company is developing... view company details

Humanigen, Inc., a biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase I/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. It also develops Ifabotuzumab, a monoclonal antibody that targets EphA3 receptor, which has completed the Phase I dose escalation portion of a Phase I/II clinical trial... view company details

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung cancer (NCSLC); and in Phase Ib clinical trial to treat NCSLC patients with Casitas B-lineage Lymphoma genetic alterations, as well as KRAS G12C inhibitor program for NSCLC adenocarcinoma patients, colorectal cancer patients, and other cancers. It also develops moc... view company details

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA T cell technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is developing TPIV100/110, which is in Phase II clinical trial to treat human epidermal growth factor receptor 2 breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of ... view company details

The world is changing fast and our industry is changing with it. The energy mix is shifting towards lower carbon sources, driven by technological advances and growing environmental concerns. In bp, we will help drive this transition - and our business will be transformed by it. We are continually looking for talented, committed and ambitious people to help us shape the face of energy for the future. view company details

Experience Columbia SC is the region's destination marketing organization. We're responsible for all marketing efforts intended to help more visitors discover all that makes Columbia the real southern hot spot... and to help bring them to your business! As the DMO for the region, we want the whole world to know what makes Columbia SC so great. Think of us as the biggest cheerleader for the heart of South Carolina. view company details

Greater Springfield Senior Services is the place to turn for resources to support older adults so they can maintain their well-being and independence in the community. We connect older adults, caregivers and professionals with the resources and services needed to help address their issues and concerns. From case management to home care services to housing information and more, our staff of caring eldercare experts is ready to offer help tailored to an individual's need. view company details

We redefine the way e-commerce product marketers and merchandisers work. By providing product information management (PIM) products and services that help create, update, refresh, maintain and distribute content about products globally, we help businesses to drive increased revenue, customer satisfaction and brand equity. More than 1000 brands and 400 customers across 19 countries rely on us to efficiently control the product flow for their globally recognized brands. view company details

iPromo's promotional products help more than 45,000 companies and organizations around the globe, including all Fortune 500 companies, discover and implement powerful product-driven marketing solutions. Our client dedicated representatives are experts in branding solutions, creating branding experiences that help our customers succeed with specific marketing goals. We sell promotional products, but more importantly, we create better promotion programs. view company details